{"organizations": [], "uuid": "fb72fc02628ccc03f80f4d06aaa35021235ff321", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 4}, "facebook": {"likes": 10, "shares": 10, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XD823_3kmIm_TOP_20180124175114.jpg", "site_section": "https://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/the-strong-case-for-health-care-spinoffs-1516876200", "country": "US", "domain_rank": 387, "title": "The Strong Case for Health-Care Spinoffs", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.3, "site_type": "news", "published": "2018-01-25T13:30:00.000+02:00", "replies_count": 0, "uuid": "fb72fc02628ccc03f80f4d06aaa35021235ff321"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/the-strong-case-for-health-care-spinoffs-1516876200", "ord_in_thread": 0, "title": "The Strong Case for Health-Care Spinoffs", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "celgene", "sentiment": "none"}, {"name": "sanofi", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "When everyone is buying, often the best strategy is to be a seller.\nDeal making in the health-care industry is booming with more than $140 billion in announced deals in the past three months, according to Dealogic. This week, drugmakers Sanofi and Celgene announced acquisitions for a combined total value of approximately $20 billion. That follows deals in sectors like hospital systems, health insurance, pharmacy benefit management and physician staffing businesses.\n... ", "external_links": [], "published": "2018-01-25T13:30:00.000+02:00", "crawled": "2018-01-25T15:06:58.005+02:00", "highlightTitle": ""}